Target intelligence / Profile preview

Bacterial ribosome A-site RNA

Molecular classification
Ribosomal RNA, Non-coding RNA, Component of ribosome, Other
01

Overview

Bacterial ribosome A-site RNA refers to a highly conserved region within the 16S ribosomal RNA (rRNA) of the small (30S) subunit of the bacterial ribosome that serves as the aminoacyl-tRNA (A) binding site. This site is critical for ensuring the accuracy (fidelity) of translation by facilitating correct codon-anticodon pairing between mRNA and incoming aminoacyl-tRNA[2][6]. The A-site's structure features bulged nucleotides (notably A1492 and A1493 in E. coli numbering) that flip out to inspect codon-anticodon pairing, switching between 'off' and 'on' conformational states to regulate translation[2]. The A-site is a prominent target for several classes of antibiotics—including aminoglycosides and tetracyclines—which bind specifically to this RNA pocket, disrupting normal translation, promoting miscoding, or preventing tRNA binding[4][5][6]. The essential function and unique structural features of the bacterial A-site make it one of the most validated and exploited targets for antibacterial drug development, although conserved elements in eukaryotic and mitochondrial ribosomes present safety concerns regarding off-target effects and toxicity[4][5][6].

Other names
Ribosomal A-site RNADecoding center A-site RNA16S rRNA A-siteAminoacyl-tRNA acceptor site
02

Mechanism of action

Inhibition of protein synthesis via binding to the A-site and disruption of decoding (aminoglycosides promote misreading or block translocation) Blockage of tRNA binding (tetracyclines prevent aminoacyl-tRNA from accessing the A-site)

03

Biological functions

Decoding center for mRNA translationFidelity control in codon-anticodon pairingMediates tRNA and release factor binding during translationEssential for protein synthesis
04

Disease associations

Infection (as a target in bacteria)Other
05

Safety considerations

Selectivity for bacterial over human ribosome A-site (mitochondrial ribosomes can be affected, leading to toxicity)Potential for resistance through mutation or methylation of the A-site RNA
06

Interacting drugs

Aminoglycoside antibiotics (e.g., paromomycin, gentamicin, streptomycin)

2 more in the full profile.

Beyond the preview

Go deeper on Bacterial ribosome A-site RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosome A-site RNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call